Performance enhancing drugs (doping agents) and sudden death - A case report and review of the literature

International Journal of Legal Medicine

Volumn 111, Issue 5, 1998, Pages 261-264

  Hausmann, R ^a   Hammer, S ^a   Betz, P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Anabolic steroids; Body building; Multi drug abuse; Sudden cardiac death

Indexed keywords

ANABOLIC AGENT;

ADULT; ARTICLE; BODY BUILDING; CASE REPORT; CLINICAL PROTOCOL; DRUG ABUSE; HEART ARREST; HUMAN; MALE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SUDDEN DEATH;

ADULT; ANABOLIC AGENTS; DEATH, SUDDEN; DOPING IN SPORTS; HUMANS; MALE; WEIGHT LIFTING;

EID: 0031873383     PISSN: 09379827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004140050165     Document Type: Article

References (60)

1. Alen M (1985) Androgenic steroid effects on liver and red cells. Br J Sports Med 19:15-20
2. Antunes CMF, Stolley PD (1977) Cancer induction by exogenous hormones: possible androgen-induced cancer. Cancer 39: 1896-1898
3. Appel HJ, Heller-Umpfenbach B, Feraudi M, Weicker H (1983) Ultrastructural and morphometric investigations on the effects of training and administration of anabolic steroids on the myocardium of guinea pigs. Int J Sports Med 4:268-274
4. Bachmann M (1996) Clenbuterol - Das Mittel der Zukunft, 6. Auflage, Sportverlag Ingenohl, Heilbronn, pp 1993-1996
5. Behrendt H, Boffin H (1977) Myocardial cell lesions caused by an anabolic hormone. Cell Tissue Res 181:423-426
6. Blast from the past! Diuretics - bodybuilding's most dangerous drugs! (1996) Muscle Media 2000, 48:112-115
7. Bowmann SJ (1989) Anabolic steroids and infarction. BMJ 299:632
8. Choo JJ, Horan MA, Little RA, Rothwell NJ (1992) Anabolic effects of clenbuterol on skeletal muscle are mediated by β2-adrenoceptor activation. Am J Physiol 263:E50-E56
9. Creagh TM, Rubin A, Evans DJ (1988) Hepatic tumors induced by anabolic steroids in an athlete. J Clin Pathol 41(4): 441-443
10. Delbeke FT, Desmet N, Debackere M (1995) The abuse of doping agents in competing body builders in Flanders (1988-1993). Int J Sports Med 16:66-70
11. Dickhuth HH, Berg A, Baumstark M, Rokitzki L, Huonker M, Keul J (1989) Doping - auch ein allgemeinmedizinisches Problem. Fortschr Med 107:585-588
12. Duchaine D (1992) Underground steroid handbook (II) Update: 1992. HLR technical books, Venice
13. Duchaine D (1996) Underground bodyopus-militant weight loss & recomposition. XIPE Press, Carson City
14. DuRant RH, Escobedo LG, Heath GW (1995) Anabolic steroid use, strength training and multiple drug use among adolescents in the United States. Pediatrics 96:23-28
15. Emery PW, Rothwell NJ, Stock MT, Winter PD (1984) Chronic effects of β2-adrenoceptor agonists on body composition and protein synthesis in the rat. Biosci Rep 4:83-91
16. Ferenchick GS (1992) Anabolic/androgenic staoid abuse and thrombosis - is there a connection? Med Hypotheses 35:27-31
17. Faenchick GS, Adelman S (1992) Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year-old weight lifter. Am Heart J 124:507-508
18. Fineschi V, Wetli CV, Di Paolo M, Baroldi G (1997) Myocardial necrosis and cocam - a quantitative morphologic study in 26 cocaine-associated deaths. Int J Legal Med 110:193-198
19. Frankle MA, Eichbag R, Zachariah SB (1988) Anabolic androgenic steroids and a stroke in an athlete: case report. Arch Phys Med Rehab 8:632-633
20. Goldmann B (1985) Liver carcinoma in an athlete taking anabolic steroids. J Am Osteopath Assoc 85:56
21. Graham S, Kennedy M (1990) Recent developments in the toxicology of anabolic steroids. Drug Saf 5:458-476
22. Grundig P, Bachmann M (1994) Anabole Steroide. Sportverlag Ingenohl, Heilbronn
23. Hartgens F, Kuipers H, Wijnen JAG, Keizer HA (1996) Body composition, cardiovascular risk factors and liver function in long term androgenic-anabolic steroids using bodybuilders three months after drus withdrawal. Int J Sports Med 17:429-433
24. Huie MJ (1994) An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sports Exac 26:408-413
25. Karch SB (ed) (1996) Anabolic steroids. In: The pathology of drug abuse. CRC Press, Boca Raton New York London Tokyo, pp 407-429
26. Karch SB, Billingham M (1986) Myocardial contraction bands revisited. Hum Pathol 17:9-13
27. Kennedy C (1993) Myocardial infarction in association with misuse of anabolic steroids. Ulster Med J 62:172-174
28. Kennedy MC, Lawrence C (1993) Anabolic steroid abuse and cardiac death. Med J Aust 158:346-348
29. Kinson G, Lyberry R, Herbert B (1991) Influences of anabolic androgens on cardiac growth and metabolism in the rat. Can J Physiol Pharmacol 69:1698-1704
30. Kuipers H, Wijnen JAG, Hartgens F, Willems SMM (1991) Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders. Int J Sports Med 12:413-418
31. Kurz H (1986) Sympathomimetika. In: Ammon HPT (ed) Arzneimittelneben- und Wechselwirkungen. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 115-127
32. Lenders JWM, Demacker PMN, Vos JA, Jansen PLM, Hoitsma AJ, van't Laar A, Thien T (1988) Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med 91: 19-23
33. Liang MTC, Paulson DJ, Kopp SJ, Glonek T, Meneses P, Gierke LW, Schwartz FN (1993) Effects of anabolic steroids and endurance exercise on cardiac performance. Int J Sports Med 14:324-329
34. Luke JL, Farb A, Virmani R, Sample RH (1990) Sudden cardiac death during exercise in a weight lifter using anabolic androgenic steroids: pathological and toxicological findings. J Forensic Sci 35:1441-1447
35. Lynberg K (1991) Myocardial infarction and death of a body builder after using anabolic steroids. Ugeskr Laeger 153:587-588
36. Madea B, Grellner W (1996) Langzeitfolgen und Todesfälle bei Anabolikaabusus. Rechtsmedizin 6:33-38
37. McLeman PA, Edwards RHT (1989) Effects of clenbuterol and propanolol on muscle mass: evidence that clenbuterol stimulates muscle β-adrenoceptors to induce hypertrophy. Biochem J 264:575-579
38. McNutt RA, Ferenchick GS, Kirlin PC, Hamlin NJ (1988) Acute myocardial infarction in a 22-year-old worldclass weight lifter using anabolic steroids. Am J Cardiol 62:164
39. McRae JC, Skene PA, Connell A, Buchan V, Lobley GE (1988) The action of β-agonist clenbuterol on protein and energy metabolism in fattening wheter lambs. Br J Nutr 9:457-465
40. Melchert RB, Welder AA (1995) Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc 27:1252-1262
41. Melchert RB, Herron TJ, Welda AA (1992) The effect of anabolic-androgenic steroids on primary myocardial cell cultures. Med Sci Sports Exerc 24:206-212
42. Musshoff F, Daldrup T, Ritsch M (1997) Anabole Steroide auf dem deutschen Schwarzmarkt. Arch Kriminol 199:153-158
43. Neumann F, Schenck B (1987) Pharmakotherapie mit Hormonen. In: Forth W, Henschler D, Rummel W (eds) Pharmakologie und Toxikologie. Bibliographisches Institut & F. A. Brockhaus, Mannheim Wien Zürich, pp 396-423
44. Overly WL, Dankhoff JA, Wang BK, Singh VD (1984) Androgens and hepatocellular carcinoma in an athlete. Ann Int Med 100:158-159
45. Palm D, Hellenbrecht D, Quiring K (1987) Pharmakologie des noradrenergen und adrenergen Systems. In: Forth W, Henschler D, Rummel W (eds) Pharmakologie und Toxikologie. Bibliographisches Institut & F. A. Brockhaus, Mannheim Wien Zürich, pp 124-168
46. Philipps WN (1991) Anabolic reference guide (Sixth Issue). Mile High Publishing, Golden
47. Reeds PJ, Hay SM, Doward PM, Palmer RM (1988) The effect of β-agonists and antagonists on muscle growth and body composition of young rats. Comp Biochem Physiol 89:337-341
48. Rothwell NJ, Stock MJ (1985) Modification of body composition by clenbuterol in normal and dystrophic mice. Biosci Rep 5:755-760
49. Rothwell NJ, Stock MJ (1987) Effect of a selective β2-adrenergic agonist (clenbuterol) on energy balance and body composition in normal and protein deficient rats. Biosci Rep 7:933-940
50. Sachtleben TR, Berg KE, Elias BA, Cheatham JP, Felix GL, Hofschire PJ (1993) The effects of anabolic steroids on myocardial structure and cardiovascular fitness. Med Sci Sports Exerc 25:1240-1245
51. Salke RC, Rowland TW, Burke EJ (1985) Left ventricular size and function in body builders using anabolic steroids. Med Sci Sports Exerc 17:701-704
52. Sano T, Motomiya T, Tamazaki H (1983) Influence of lipids on platelet activation in vivo. Thromb Res 31:675-684
53. Soares J, Duarte J (1991) Effects of training and an anabolic steroid on murine red skeletal muscle - a stereological analysis. Acta Anat (Basel) 142:183-187
54. Svorcik C, Bicikova L (1978) Effects of drugs on the stimulation threshold of the human heart. Cor Vasa 20:184-195
55. Takala T, Ramo P, Kiviluoma K (1991) Effects of training and anabolic steroids on collagen synthesis in dog heart. Eur J Appl Physiol 62:1-6
56. Tseng Y, Rockhold R, Hoskins B (1994) Cardiovascular toxicities of nandrolone and cocaine in spontaneously hypertensive rats. Fund Appl Toxicol 22:113-122
57. Westaby D, Ogle SJ, Paradinas FJ, Randell JB, Murray-Lyo IM (1977) Liver damage from long-term methyl-testosterone. Lancet 261:263
58. Yesalis C, Anderson W, Buckley W, Wright J (1990) Incidence of the non-medical use of anabolic-androgenic steroids. In: Anabolic steroid abuse. National Institute on Drug Abuse, Rockville, pp 97-112
59. Yesalis C, Kennedy N, Kopstein A (1993) Anabolic-androgenic steroid use in the United States. JAMA 270:1217-1221
60. Zack F, Terpe H, Hammer U, Wegener R (1996) Fibromuscular dysplasia of coronary arteries as a rare cause of death. Int J Legal Med 108:215-218